Navigation Links
Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Date:6/24/2008

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward-looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for Genasense(R) from the U.S. Food and Drug Administration ("FDA") or European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its products or product candidates;

-- the Company's ability to enter into and successfully execute license and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow projections, the Company's ability to obtain sufficient financing to maintain the Company's planned operations, or the Company's risk of bankruptcy if it is unsuccessful in obtaining such financing or in securing shareholder approval to increase the number of shares authorized for issuance under the Company's certificate of incorporation, as required by the transactional documents in our recent financing;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and its officers and directors and any proposed settlement of such litigation; and

-- the other risks described under Certain Risks and Uncertainties Related to the Company's Business, as contained in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. T
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Lifts Clinical Hold on Gentas Tesetaxel, a Leading Oral Taxane
2. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
5. Genta Receives Key Patent Related to Oral Gallium Compound G4544
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. Genta Clinical Programs Featured at American Society of Hematology Meeting
11. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Ill., Dec. 15 Fenwal Inc., a ... collection, separation, safety and availability, announced today that ... Fenwal approval to market InterSol ® platelet ... solution is a specialized product used in ... a vital blood component used to prevent or ...
(Date:12/15/2009)... -- ,, Reportlinker.com announces that a new ... catalogue: ,, Hepatitis B Vaccines - ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis ... Forecasts to 2015 ,, Summary ... report, "Hepatitis B Vaccines - Pipeline Analysis ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, http://www.reportlinker.com/p0168192/Top-Ten-Worlds-Leading-Orthopedics-Companies.html ... the competitive environment is unquestionably one ... the task crucial to business survival, ... competitive intelligence is vital to the ...
Breaking Medicine Technology:Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Satellite Dialysis Opens New Center in San Leandro CA 61499 1Satellite Dialysis Opens New Center in San Leandro CA 61499 2Vivakor Inc Announces Stock Dividend 14870 1Vivakor Inc Announces Stock Dividend 14870 2Vivakor Inc Announces Stock Dividend 14870 3Vivakor Inc Announces Stock Dividend 14870 4Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 1Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 2Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 3Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 4
... be placed in the brain to treat a stroke as ... Annual International Symposium on Endovascular Therapy (ISET).Stents have long been ... to prevent heart attacks and in the neck to prevent ... to treat occurring heart attacks by opening up the blocked ...
... the international,investment house specialising in medical sciences, said ... pioneering stem cell treatments if it is,to remain ... Professor Sir Christopher Evans, founder ... plc has received approval from the UK,Medicines and ...
Other Medicine Technology:Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 2Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 3UK Must Maintain its Momentum in Stem Cell Expertise 2
(Date:12/16/2009)... Socks and Insoles Awarded American Podiatric Medical Association’s Seal of ... ... December 15, 2009 -- As shoppers continue their search for ... green” and shop for items that are considered healthy for ... earth-friendly footwear products, many of today’s most stylish items are ...
(Date:12/16/2009)... development of products that help survivors of stroke and other ... publication of an interview with the inventors of their brand ... Therapy and Rehab Medicine, vol. 20, issue 20, page 26, ... ... (PRWEB) December 16, 2009 -- In the publication, ...
(Date:12/16/2009)... and what would be the perfect gift to give that special ... Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty products ... their best! , ... (PRWEB) December 16, 2009 -- ... a person get that special woman who has everything? Why stem ...
(Date:12/15/2009)... a new electrophoretic method for detecting MIRCERA and ... technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for ... of SDS-PAGE for detecting other EPOs. Details ... the World Anti-Doping Agency (WADA), appear in the ... published by Wiley-Blackwell. , MIRCERA (methoxy polyethylene ...
(Date:12/15/2009)... Consumer Watchdog Calls For Preserving State Authority, Ban ... ,, WASHINGTON, Dec. 15 Consumer ... provision for those over 55 and the public ... But the group said that the Senate must ... weakened bill to prevent ceding the entire health ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Researchers discover novel method for detecting MIRCERA 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5
... the Proceedings for the 2003 Annual Meeting of the American ... be a more effective means of cancer prognosis than measuring ... woman’s diet. None of the measures for detecting breast cancer ... University of Texas.// ,But, he says that levels ...
... study of patients with viral encephalitis by researchers ... condition could cause seriouys movement,problems. The investigators studied ... whom had West Nile virus. They found that ... care, while four developed severe movement disorders like,tremor, ...
... This respiratory diesease that can be fatal and threatens ... 1485 cases have been identified worldwide with more than ... Italian doctor who discovered this illness recently succumbed to ... expert on communicable diseases woking for WHO , ,was ...
... detecting upper urinary tract transitional cell carcinoma by a ... checks for fibrinogen/fibrin degradation products. It appears to be ... cytology. The Researchers compared the efficacy of two types ... the diagnosis// of transitional cell carcinoma in patients with ...
... approved a new patch developed by Watson Pharmaceuticals Inc., ... called Oxytrol (generic: oxybutynin transdermal system) reduces urinary urge ... drug's maker. Oral forms of oxybutynin has been around ... popular with patients due to side effects like// dry ...
... condition of the bladder wall. It typically affects young ... Investigators are testing the bacteria Bacillus Calmette-Guerin(BCG), which from ... interstitial cystitis, by inserting six installations into the bladders ... of BCG// also showed that 60 percent of patients ...
Other Medicine News:
"Small" redefined for Holter recorders!...
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
LOGIQ Book XP provides you the next generation performance in a compact platform....
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
Medicine Products: